Agent successfully gathered core product information (what, who, pricing, differentiation) from the site's homepage and pricing page, but identified significant gaps—scientific validation data, company provenance, and the biological basis for blood-based microbiota detection—that the site did not expose. Navigation was straightforward; incompleteness was due to sparse site content, not poor findability.

• ›Site content was foundational but shallow: homepage and pricing page provided positioning and pricing, but the agent had to flag biological plausibility questions and absence of clinical trial / peer-review evidence entirely from model reasoning, not from fetched content.
• ›Agent discovered all fetched URLs via direct memory (3 homepage fetches) or by following the pricing link—no search results were used, indicating the site's information architecture exposed pricing and main value prop but not deeper substantiation.
• ›The final response correctly distinguished between what the site claimed (technology, target audience, differentiators) and what it did not provide (founder/team info, scientific validation, detailed consultation pricing), grounding skepticism appropriately in retrieval gaps rather than speculation.
• ›Pricing was fully transparent (€149 single, €289 pair, student discounts available), but one upsell (20-minute expert consultation) had no published price—site content was sufficient for core pricing but incomplete for total cost of ownership.
• ›Agent correctly identified an unresolved biological tension: the site's emphasis on blood-based microbiota analysis conflicts with standard microbiome science (gut microbiota live in stool), suggesting either novel methodology or a positioning gap—the site did not explain or justify this approach, leaving the agent to flag it as a credibility concern.